Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
19.86
0.09 (0.46%)
At close: Aug 15, 2025, 10:02 AM
0.46% (1D)
| Bid | 19.79 |
| Market Cap | 1.17B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -94.83M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -9.98 |
| Forward PE | -7.13 |
| Analyst | Buy |
| Ask | 19.92 |
| Volume | 50,827 |
| Avg. Volume (20D) | 500,311 |
| Open | 19.95 |
| Previous Close | 19.77 |
| Day's Range | 19.81 - 20.79 |
| 52-Week Range | 13.30 - 30.03 |
| Beta | 1.03 |
About ELVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+11.44%
Enliven Therapeutics shares are trading higher. Th...
Unlock content with
Pro Subscription
3 months ago
-10.41%
Enliven Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.
